A self-removing genetic method to control mosquitoes that spread dengue and other viruses

Self-Eliminating Strategy To Control Gene Drive

['FUNDING_R01'] · TEXAS A&M AGRILIFE RESEARCH · NIH-11320437

This project develops a genetic approach that can spread virus-blocking traits through Aedes aegypti populations and then remove those added genes afterward to help lower dengue, yellow fever, and chikungunya risk.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorTEXAS A&M AGRILIFE RESEARCH (nih funded)
Locations1 site (College Station, UNITED STATES)
Trial IDNIH-11320437 on ClinicalTrials.gov

What this research studies

Researchers are building a CRISPR-based gene drive that can both push virus-resistance genes into mosquito populations and trigger their own removal after a set phase. They will run multigeneration cage experiments in fruit flies and Aedes aegypti mosquitoes to see how the drive spreads and how reliably the self-eliminating mechanism works. The team will study DNA repair, local genome features, nuclease properties, and chromosomal position to understand what helps or hinders both drive and removal. The aim is to design a controllable, reversible genetic tool that could reduce disease transmission by these mosquitoes.

Who could benefit from this research

Good fit: People living in regions where Aedes aegypti spreads dengue, yellow fever, or chikungunya would be most likely to benefit from this work in the future.

Not a fit: People affected by conditions not transmitted by Aedes aegypti or who live outside regions with these mosquitoes are unlikely to receive direct benefit from this project.

Why it matters

Potential benefit: If successful, this could enable community-level reduction of mosquito-borne viruses using a genetic tool that can be turned off or removed for added safety.

How similar studies have performed: CRISPR-based gene drives have shown success in laboratory fruit flies and in some malaria mosquito work, but controllable, self-eliminating drives in Aedes aegypti are newer and remain experimental.

Where this research is happening

College Station, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.